New Zoetis Drug Could Could Provide a Boost to Pet Care ETF
September 10, 2019 at 11:27 AM EDT
The ProShares Pet Care ETF (CBOE: PAWZ), the first and still the only dedicated pet care ETF, has plenty of favorable tailwinds. Another one may be arriving in the form of regulatory approval of Simparica Trio, a canine drug made by PAWZ holding Zoetis (NYSE: ZTS). Shares of Zoetis accounted for...